These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31081439)

  • 1. The Australian drug harms ranking study.
    Bonomo Y; Norman A; Biondo S; Bruno R; Daglish M; Dawe S; Egerton-Warburton D; Karro J; Kim C; Lenton S; Lubman DI; Pastor A; Rundle J; Ryan J; Gordon P; Sharry P; Nutt D; Castle D
    J Psychopharmacol; 2019 Jul; 33(7):759-768. PubMed ID: 31081439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug harms in the UK: a multicriteria decision analysis.
    Nutt DJ; King LA; Phillips LD;
    Lancet; 2010 Nov; 376(9752):1558-65. PubMed ID: 21036393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New Zealand drug harms ranking study: A multi-criteria decision analysis.
    Crossin R; Cleland L; Wilkins C; Rychert M; Adamson S; Potiki T; Pomerleau AC; MacDonald B; Faletanoai D; Hutton F; Noller G; Lambie I; Sheridan JL; George J; Mercier K; Maynard K; Leonard L; Walsh P; Ponton R; Bagshaw S; Muthukumaraswamy S; McIntosh T; Poot E; Gordon P; Sharry P; Nutt D; Boden J
    J Psychopharmacol; 2023 Sep; 37(9):891-903. PubMed ID: 37353972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people.
    Cheeta S; Halil A; Kenny M; Sheehan E; Zamyadi R; Williams AL; Webb L
    BMJ Open; 2018 Nov; 8(11):e021109. PubMed ID: 30401725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The National Ambulance Surveillance System: A novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records.
    Lubman DI; Matthews S; Heilbronn C; Killian JJ; Ogeil RP; Lloyd B; Witt K; Crossin R; Smith K; Bosley E; Carney R; Wilson A; Eastham M; Keene T; Shipp C; Scott D
    PLoS One; 2020; 15(1):e0228316. PubMed ID: 32004349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
    Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.
    Morgan CJ; Noronha LA; Muetzelfeldt M; Feilding A; Curran HV
    J Psychopharmacol; 2013 Jun; 27(6):497-506. PubMed ID: 23438502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European rating of drug harms.
    van Amsterdam J; Nutt D; Phillips L; van den Brink W
    J Psychopharmacol; 2015 Jun; 29(6):655-60. PubMed ID: 25922421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Grigoleit T; Hermle L; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Luckhaus C; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck GA; Wodarz N; McAnally H; Scherbaum N
    Front Psychiatry; 2020; 11():592199. PubMed ID: 33192740
    [No Abstract]   [Full Text] [Related]  

  • 10. Ranking the harm of non-medically used prescription opioids in the UK.
    van Amsterdam J; Phillips L; Henderson G; Bell J; Bowden-Jones O; Hammersley R; Ramsey J; Taylor P; Dale-Perera A; Melichar J; van den Brink W; Nutt D
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):999-1004. PubMed ID: 26382614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between alcohol, marijuana, illegal drug use and current use of E-cigarette among youth and young adults in Canada: results from Canadian Tobacco, Alcohol and Drugs Survey 2017.
    Mehra VM; Keethakumar A; Bohr YM; Abdullah P; Tamim H
    BMC Public Health; 2019 Sep; 19(1):1208. PubMed ID: 31477067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulation.
    Rogeberg O; Bergsvik D; Phillips LD; van Amsterdam J; Eastwood N; Henderson G; Lynskey M; Measham F; Ponton R; Rolles S; Schlag AK; Taylor P; Nutt D
    Int J Drug Policy; 2018 Jun; 56():144-152. PubMed ID: 29459211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring The Harms Caused by Illicit Drugs. A New Methodology for Estimating Drug Harm Index.
    Novin MH; Razaghi E; Farzadfar F; Tarokh MJ; Rouhifard M
    Subst Use Misuse; 2024; 59(13):1870-1878. PubMed ID: 39069745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggression in the Australian night time economy: A comparison of alcohol only versus alcohol and illicit drug consumption.
    Norman T; Peacock A; Bruno R; Chan G; Morgan A; Voce I; Droste N; Taylor N; Coomber K; Miller PG
    Drug Alcohol Rev; 2019 Nov; 38(7):744-749. PubMed ID: 31642569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of socioeconomic status with consumption of cigarettes, illicit drugs, and alcohol.
    Marzban M; Hadji M; Gholipour M; Rashidian H; Rezaianzadeh A; Hasanzadeh J; Haghdoost AA; Rahimi-Movaghar A; Ghiasvand R; Moradi A; Khavari-Daneshvar H; Weiderpass E; Kamangar F; Zendehdel K
    J Ethn Subst Abuse; 2019; 18(2):309-318. PubMed ID: 28820664
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use among youth: National survey data support a common liability of all drug use.
    DuPont RL; Han B; Shea CL; Madras BK
    Prev Med; 2018 Aug; 113():68-73. PubMed ID: 29758306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggression and violence at ambulance attendances where alcohol, illicit and/or pharmaceutical drugs were recorded: A 5-year study of ambulance records in Victoria, Australia.
    Coomber K; Curtis A; Vandenberg B; Miller PG; Heilbronn C; Matthews S; Smith K; Wilson J; Moayeri F; Mayshak R; Lubman DI; Scott D
    Drug Alcohol Depend; 2019 Dec; 205():107685. PubMed ID: 31704380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation in Australian drug treatment programs for individuals engaging in high-risk substance use: Data from a nationally representative sample.
    Leung J; Yimer TM; Chiu V; Hall WD; Connor JP; Chan GCK
    Drug Alcohol Rev; 2024 Mar; 43(3):688-693. PubMed ID: 38087847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi criteria decision analysis (MCDA) for evaluating and appraising government policy responses to non medical heroin use.
    Rolles S; Schlag AK; Measham F; Phillips L; Nutt D; Bergsvik D; Rogeberg O
    Int J Drug Policy; 2021 May; 91():103180. PubMed ID: 33640213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.